跳至主導覽 跳至搜尋 跳過主要內容

Inhibitory effects of propofol on Th17 cell differentiation

  • Chi Chien Lin
  • , Der Yuan Chen
  • , Kuo Tung Tang
  • , Ya Hsuan Chao
  • , Ching Hui Shen
  • , Ping Wing Lui*
  • *此作品的通信作者
  • National Chung Hsing University
  • China Medical University Taichung
  • Asia University Taiwan
  • Veterans General Hospital-Taichung Taiwan
  • National Yang Ming Chiao Tung University

研究成果: 期刊稿件 › 文章 › 同儕審查

3 引文 斯高帕斯(Scopus)

摘要

Propofol (2,6-diisopropylphenol) is probably the most widely used intravenous anesthetic agent in daily practice. It has been reported to show immunomodulatory activity. However, the effect of propofol on the differention of T cells remains unclear. In this study, we demonstrated for the first time that propofol inhibited both interleukin (IL)-6 plus transforming growth factor-β (TGF-β)-induced Th17 cell differentiation in vitro and in LPS-challenged mice. Propofol also suppressed the IL-6-induced phosphorylation of Janus kinase-2 (JAK2)/signal transducer and activator of transcription (STAT3) pathway, a cytokine-activated essential transcription factor in Th17 cell development, which occurred concomitantly with the enhancement of suppressor of cytokine signaling-3 (SOCS3) expression involved in the downregulation of STAT3 phosphorylation. These data extend our knowledge of the immunosuppressive effects of propofol and their underlying mechanism.

原文英語
頁(從 - 到)211-218
頁數8
期刊Immunopharmacology and Immunotoxicology
卷39
發行號4
DOIs
出版品狀態已出版 - 04 07 2017
對外發佈是

文獻附註

Publisher Copyright:
© 2017 Informa UK Limited, trading as Taylor & Francis Group.

指紋

深入研究「Inhibitory effects of propofol on Th17 cell differentiation」主題。共同形成了獨特的指紋。

引用此